Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Lars M. Wagner, Maryam Fouladi, Atif Ahmed, Mark D. Krailo, Brenda Weigel, Steven G. Dubois, L. Austin Doyle, Helen Chen, Susan M. Blaney

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences